Search research articles
Contact Us
Filters
Showing results (31-40 of 60) with videos related to
Page
of 6
Sort By:
Endocrinology and Metabolism (Seoul, Korea)
|
November 7, 2023
Familial Correlation and Heritability of Hand Grip Strength in Korean Adults (Korea National Health and Nutrition Examination Survey 2014 to 2019)
Seong Hee Ahn, Eun Byeol Park, Seongha Seo, et al.
Plos One
|
February 7, 2025
The effect of SGLT2 inhibitor in patients with type 2 diabetes and atrial fibrillation
Yongin Cho, Sung-Hee Shin, Min-Ae Park, et al.
Diabetes & Metabolism Journal
|
January 29, 2019
Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 Inhibitors
Ji Yeon Lee, Yongin Cho, Minyoung Lee, et al.
Scientific Reports
|
November 11, 2020
Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression
Minyoung Lee, Eugene Shin, Jaehyun Bae, et al.
Medicine
|
September 10, 2022
Prediction of antidiabetic effect after gastrectomy with Roux-en-Y reconstruction in patients with gastric cancer and type 2 diabetes
Seong Ha Seo, Yongin Cho, Yoon Seok Heo, et al.
BMC Medicine
|
March 21, 2022
Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study)
Yongin Cho, Hyungjin Rhee, Young-Eun Kim, et al.
Diabetes & Metabolism
|
October 18, 2022
Prevalence and risk of diabetic complications in young-onset versus late-onset type 2 diabetes mellitus
Yongin Cho, Hye-Sun Park, Byung Wook Huh, et al.
Journal of Clinical Medicine
|
August 3, 2019
Prevalence of Thyroid Disease in Patients Surgically Treated for Pituitary Disease
Daham Kim, Yongin Cho, Cheol Ryong Ku, et al.
BMC Medicine
|
May 7, 2025
Synergistic benefit of thiazolidinedione and sodium-glucose cotransporter 2 inhibitor for metabolic dysfunction-associated steatotic liver disease in type 2 diabetes: a 24-week, open-label, randomized controlled trial
Minyoung Lee, Sukchul Hong, Yongin Cho, et al.
Yonsei Medical Journal
|
August 29, 2022
Effect of Dapagliflozin in Combination with Lobeglitazone and Metformin in Korean Patients with Type 2 Diabetes in Real-World Clinical Practice
Da Hea Seo, Young Ju Suh, Yongin Cho, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 60) with videos related to
Sort By:
Page
of 6
Endocrinology and Metabolism (Seoul, Korea)
|
November 7, 2023
Familial Correlation and Heritability of Hand Grip Strength in Korean Adults (Korea National Health and Nutrition Examination Survey 2014 to 2019)
Seong Hee Ahn, Eun Byeol Park, Seongha Seo, et al.
Plos One
|
February 7, 2025
The effect of SGLT2 inhibitor in patients with type 2 diabetes and atrial fibrillation
Yongin Cho, Sung-Hee Shin, Min-Ae Park, et al.
Diabetes & Metabolism Journal
|
January 29, 2019
Predictors of the Therapeutic Efficacy and Consideration of the Best Combination Therapy of Sodium-Glucose Co-transporter 2 Inhibitors
Ji Yeon Lee, Yongin Cho, Minyoung Lee, et al.
Scientific Reports
|
November 11, 2020
Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression
Minyoung Lee, Eugene Shin, Jaehyun Bae, et al.
Medicine
|
September 10, 2022
Prediction of antidiabetic effect after gastrectomy with Roux-en-Y reconstruction in patients with gastric cancer and type 2 diabetes
Seong Ha Seo, Yongin Cho, Yoon Seok Heo, et al.
BMC Medicine
|
March 21, 2022
Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study)
Yongin Cho, Hyungjin Rhee, Young-Eun Kim, et al.
Diabetes & Metabolism
|
October 18, 2022
Prevalence and risk of diabetic complications in young-onset versus late-onset type 2 diabetes mellitus
Yongin Cho, Hye-Sun Park, Byung Wook Huh, et al.
Journal of Clinical Medicine
|
August 3, 2019
Prevalence of Thyroid Disease in Patients Surgically Treated for Pituitary Disease
Daham Kim, Yongin Cho, Cheol Ryong Ku, et al.
BMC Medicine
|
May 7, 2025
Synergistic benefit of thiazolidinedione and sodium-glucose cotransporter 2 inhibitor for metabolic dysfunction-associated steatotic liver disease in type 2 diabetes: a 24-week, open-label, randomized controlled trial
Minyoung Lee, Sukchul Hong, Yongin Cho, et al.
Yonsei Medical Journal
|
August 29, 2022
Effect of Dapagliflozin in Combination with Lobeglitazone and Metformin in Korean Patients with Type 2 Diabetes in Real-World Clinical Practice
Da Hea Seo, Young Ju Suh, Yongin Cho, et al.
Page
of 6